The Closure of the U.S. Narcotics Farms in the mid-1970s ended a federal experiment that had joined treatment, job training, medical care, and addiction research in rural institutions. The farms helped shape addiction medicine and the scientific understanding of addiction, but their closure followed an ethics scandal over the improper use of addicted people as research subjects. Their history therefore resists a simple account of either institutional failure or progress: care and knowledge developed alongside exploitation.

Origins and Purpose

In the mid-to-late 1930s, psychiatrist Lawrence Kolb Sr. oversaw the opening of two U.S. Narcotics Farms, one in Lexington, Kentucky, and the other in Fort Worth, Texas. They formed part of the federal government’s New Deal for the Drug Addict. In rural settings, the farms received people sent by court mandate as well as people who volunteered. Residents could receive treatment, job training, and medical care, while government scientists conducted research using the farms’ captive populations.

The arrangement brought people understood as addicted into a federal institution that offered more than confinement: treatment and practical support were among its stated functions. At the same time, the research setting depended on a population whose circumstances made the ethics of participation a central question in the farms’ later history.

A Shift in the Understanding of Addiction

Kolb had earlier argued that addiction was confined to people with personality defects, distinguishing people prescribed opiates by doctors from those who became addicted through illicit use. He initially treated the latter as more blameworthy and as criminals rather than patients who deserved care. Evidence from colleagues changed his position: people he considered normal, including the 10 to 15 percent of patients who were health-care professionals, could also become addicted after opioid exposure.

That revision challenged a division between supposedly respectable patients and supposedly vicious users. The farms’ research helped establish addiction medicine and supported a scientific conception of addiction as chronic and prone to relapse. The significance of that work was substantial, but it did not erase the ethical costs of conducting experiments on people in the farms’ custody.

Closure and Legacy

Both farms closed in the mid-1970s amid an ethics scandal over the improper exploitation of addicted people as research subjects. The closure marked a limit on a federal program whose medical and research contributions had developed within a deeply unequal relationship between institutions and the people they held. The farms’ legacy included the establishment of the National Institute on Drug Abuse and a lasting scientific framework for understanding addiction as a chronic, relapsing disease.

The book sets that history against a later pattern: courts often sent people with addiction to prison when reliable treatment was difficult to obtain, while many drug courts continued to bar medication-assisted treatment despite scientific support for its use. This contrast does not make the farms an uncomplicated model to restore. It shows instead how the history of treatment contains both real advances and serious harms, while access to care remains shaped by institutional choices.